UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 25, 2012 (January 19, 2012)
Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 001-35331 | 46-2492228 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
830 Crescent Centre Drive, Suite 610, Franklin, Tennessee 37067
(Address of Principal Executive Offices)
(615) 861-6000
(Registrant’s Telephone Number, including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
Effective January 19, 2012, the Board of Directors (the “Board”) of Acadia Healthcare Company, Inc. (the “Company”) increased the number of directors constituting the Board from seven to eight and elected Wade D. Miquelon to fill the vacancy created by the increase in the number of directors. The Board elected Mr. Miquelon to serve in the class of directors whose initial term expires at the Company’s annual meeting of stockholders in 2014. It is expected that Mr. Miquelon will serve as a member of the Audit Committee of the Board.
Mr. Miquelon has been Executive Vice President and Chief Financial Officer of Walgreen Co. since July 2009, having joined Walgreens in June 2008 as Senior Vice President and Chief Financial Officer. From 2006 to 2008, Mr. Miquelon served as Executive Vice President and Chief Financial Officer of Tyson Foods, Inc.
A copy of the press release announcing Mr. Miquelon’s election to the Board is filed as Exhibit 99 to this report.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit No. |
Description | |
| 99 | Press Release of Acadia Healthcare Company, Inc., dated January 25, 2012 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ACADIA HEALTHCARE COMPANY, INC. | ||||||
| Date: January 25, 2012 | By: | /s/ Christopher L. Howard | ||||
| Christopher L. Howard | ||||||
| Executive Vice President and General Counsel | ||||||
Exhibit Index
| Exhibit No. |
Description | |
| 99 | Press Release of Acadia Healthcare Company, Inc., dated January 25, 2012 | |
Exhibit 99
Contact:
Brent Turner
Co-President
(615) 861-6000
Acadia Healthcare Names Wade Miquelon, EVP and CFO of Walgreens,
to Board of Directors
FRANKLIN, Tennessee, January 25, 2012— Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that it has named Wade D. Miquelon to the Board of Directors. Since July 2009, Mr. Miquelon has been Executive Vice President and Chief Financial Officer of Walgreen Co. Mr. Miquelon joined Walgreens in June 2008 as Senior Vice President and Chief Financial Officer. Prior to Walgreens, he was Executive Vice President and Chief Financial Officer at Tyson Foods, Inc. from 2006 to 2008. From 1989 to 2006, Mr. Miquelon served Procter & Gamble in a number of positions of increasing responsibility, most recently for three years as Vice President—Finance, Western Europe, the senior most financial officer responsible for the 17-country Western Europe operation. Among other positions during his tenure at P&G, Mr. Miquelon was the head of Finance and Accounting for the ASEAN, Australasia, and India region, served as Director and Investment Partner of I Ventures, a P&G venture capital fund, and co-founded and served as Chief Financial Officer and Senior Vice President of Business Development/Human Resources of Emmperative, Inc., an enterprise marketing management software joint venture between P&G and other entities.
Joey Jacobs, Chairman and Chief Executive Officer of Acadia, remarked, “Wade Miquelon brings tremendous expertise in a range of disciplines to Acadia, as well as valuable perspectives from his work with both large established companies and young growth companies. We welcome Wade to the Board, confident of his ability to contribute to the Company’s long-term growth in earnings and shareholder value.”
About Acadia
Acadia is a provider of inpatient behavioral health care services. Acadia operates a network of 29 behavioral health facilities with approximately 1,970 licensed beds in 18 states. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.
- END -